생명과학 기기 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Life Science Instrumentation Market size is expected to reach USD 98.94 Billion in 2034 from USD 54.22 Billion (2025) growing at a CAGR of 6.91% during 2026-2034.

The Global Life Science Instrumentation Market continues to grow due to expanding research activities, rising diagnostic testing volumes, and technological advancements. Increased adoption of sequencing systems, PCR technologies, chromatography, and cell-analysis platforms is supporting strong demand. Growth in pharmaceutical R&D and biologics manufacturing further strengthens the need for advanced analytical instruments. Expanding research infrastructure in emerging economies also contributes to market expansion.

Key drivers include automation in laboratories, high-throughput screening requirements, and integration of digital technologies for data analysis. Growing genomics research programs and precision medicine initiatives are increasing instrument adoption worldwide. Additionally, investments in biotechnology startups and academic research funding are sustaining long-term equipment demand across various applications.

Future growth will be shaped by AI integration, miniaturization of devices, and cloud-based laboratory data management systems. Service-based instrument models and improved workflow automation are expected to enhance efficiency. Companies focusing on integrated hardware-software ecosystems and strong after-sales support will likely benefit from sustained market expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Chromatography
• Spectroscopy
• Mass Spectroscopy
• Molecular Spectroscopy
• Atomic Spectroscopy
• PCR
• qPCR
• dPCR
• Liquid Handling
• Centrifuges
• Flow Cytometry
• Electrophoresis
• Cell Counting
• Others

By End User

• Pharma & Biotech companies
• Agri and Food Industry
• Diagnostic Labs
• Others

COMPANIES PROFILED

• Agilent Technologies, Merck KGaA, Horiba, Hitachi HighTechnologies Corporation, PerkinElmer Inc, Qiagen NV, Becton, Dickinson and Company, Thermo Fisher Scientific Inc, Eppendorf AG, BioRad Laboratories Inc,
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Chromatography Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Spectroscopy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Mass Spectroscopy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Molecular Spectroscopy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Atomic Spectroscopy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. PCR Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. qPCR Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.9. dPCR Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.10. Liquid Handling Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.11. Centrifuges Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.12. Flow Cytometry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.13. Electrophoresis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.14. Cell Counting Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.15. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET: BY END USER 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End User
• 5.2. Pharma & Biotech companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Agri and Food Industry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Diagnostic Labs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Product
  • 6.2.2 By End User
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Product
  • 6.3.2 By End User
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Product
  • 6.4.2 By End User
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Product
  • 6.5.2 By End User
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Product
  • 6.6.2 By End User
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL LIFE SCIENCE INSTRUMENTATION INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Agilent Technologies
  • 8.2.2 Merck KGaA
  • 8.2.3 Horiba
  • 8.2.4 Hitachi High-Technologies Corporation
  • 8.2.5 PerkinElmer Inc
  • 8.2.6 Qiagen N.V
  • 8.2.7 Becton
  • 8.2.8 Dickinson And Company
  • 8.2.9 Thermo Fisher Scientific Inc
  • 8.2.10 Eppendorf AG
  • 8.2.11 Bio-Rad Laboratories Inc.,